G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $14,839,000 | +146.2% | 483,990 | +33.3% | 0.80% | +206.5% |
| Q1 2019 | $6,027,000 | +246.8% | 363,051 | +807.6% | 0.26% | +130.1% |
| Q2 2018 | $1,738,000 | +17.3% | 40,000 | 0.0% | 0.11% | -0.9% |
| Q1 2018 | $1,482,000 | -53.2% | 40,000 | -75.0% | 0.11% | -57.0% |
| Q4 2017 | $3,170,000 | -93.6% | 159,780 | -94.0% | 0.26% | -94.1% |
| Q3 2017 | $49,793,000 | +6.4% | 2,684,244 | 0.0% | 4.50% | -16.3% |
| Q2 2017 | $46,813,000 | – | 2,684,244 | – | 5.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |